超越被动免疫力:三例新生儿流感病例突显了错过母体疫苗接种的影响
Irina Profir1,2, Cristina-Mihaela Popescu2,3, Gabriel Valeriu Popa3
1Clinical Medical Department, Faculty of Medicine and Pharmacy, "Dunărea de Jos" University of Galați, 800216 Galati, Romania.
Clinics and practice
|July 25, 2025
概括
母体流感疫苗接种对于新生儿的保护至关重要. 未接种疫苗的母亲婴儿面临流感和百日咳的重大风险,这凸显了新生儿早期诊断和抗病毒治疗的必要性.
科学领域:
- 新生儿医学 新生儿医学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 由于免疫系统不成熟,新生儿流感带来了重大风险.
- 孕产妇流感免疫提供了被动抗体转移,保护新生儿.
- 怀孕期间疫苗接种覆盖率低,使新生儿容易受到伤害.
研究的目的:
- 提出三例实验室确认的新生儿流感病例.
- 审查新生儿流感的临床表现,并发症和结局.
- 强调母体疫苗接种对于预防新生儿严重后果的重要性.
主要方法:
- 三名新生儿的病例系列与实验室确认的流感.
- 对临床表现,并发症,母体疫苗接种状态和结果的系统分析.
- 关于新生儿流感和并发感染的文献综述.
主要成果:
- 这三名新生儿均出生于未接种疫苗的母亲,并出现发烧和呼吸系统症状.
- 一名新生儿同时感染了 Bordetella pertussis,导致更严重的症状.
- 所有婴儿都得到了及时的抗病毒治疗 (oseltamivir) 并需要补充氧气,在6-7天内完全恢复.
结论:
- 新生儿流感会导致显著的发病率,特别是在未接种疫苗的母亲的婴儿.
- 早期诊断和及时的抗病毒治疗是积极结果的关键.
- 针对流感和百日咳的母体免疫对于新生儿的保护至关重要.
更多相关视频
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
1.8K
05:21A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
25.4K
相关概念视频
Vaccinations
45.3K
Overview
45.3K
Development of Immunocompetence
449
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
449
